Study of genetics in people with uveitis
Part of Eyes & vision, Infections clinical trials.
This study looks at genetic (inherited) differences in people with uveitis. The goal is to better understand what may cause uveitis and potentially help with future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with uveitis
- The study includes infectious causes of uveitis too, like herpes or toxoplasmosis
- You can give informed consent (sign permission or have a legal process to allow participation)
- A blood sample can be collected from you for testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special eye scan (optical coherence tomography) to look at inflammation in the front part of the eye. It may help doctors better measure uveitis activity and guide care by improving how inflammation is seen on scans.
This study follows people who have been diagnosed with uveitis (inflammation inside the eye). It helps researchers better understand the condition and how people do over time.
This study looks at children with long-term eye inflammation that is not caused by an infection. It aims to learn more about the condition and how to better help patients.
This trial uses a new genetic test to find the cause of eye inflammation when standard tests haven't. The goal is to see if this approach can identify hidden infections and help doctors choose the right treatment to protect your vision.
This study looks at uveitis, a type of eye inflammation, in children. Researchers want to learn more about different types of uveitis and how they affect children, whether the inflammation is new or has been going on for a while.
This study tests a new drug (GenSci048) for people with active, non-infectious uveitis in the middle or back of the eye, who are already taking oral steroids. The goal is to see if the drug can better control inflammation and reduce the need for steroids.
Hear when a new Uveitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.